BRCA1 and cancer: In Figure 2, the cell numbers counted from 24 h to 72 h indicated that cucurbitacin B treatment to these BRCA1 knocked down cancer cells could impede growth for approximately 50 percent as compared to the fast growing, untreated BRCA1 knocked-down partner.